Biodexa Pharmaceuticals Shareholders Equity (Quarterly) Trends

Biodexa Pharmaceuticals PLC (BDRX)

5.68 -0.23 (-3.89%) USD | NASDAQ | Nov 04, 16:00

5.68 0.00 (0.00%) After-Hours: 20:00

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
June 30, 2024	11.04M
June 30, 2024	11.04M
December 31, 2023	5.959M
June 30, 2023	6.684M
June 30, 2023	6.684M
December 31, 2022	3.827M
June 30, 2022	9.086M
June 30, 2022	9.086M
December 31, 2021	14.11M
June 30, 2021	5.193M
June 30, 2021	5.193M
December 31, 2020	9.156M
June 30, 2020	5.597M
June 30, 2020	5.597M
December 31, 2019	25.64M

Date	Value
June 30, 2019	31.37M
June 30, 2019	31.37M
December 31, 2018	21.47M
June 30, 2018	30.56M
June 30, 2018	30.56M
December 31, 2017	46.86M
June 30, 2017	47.90M
June 30, 2017	47.90M
December 31, 2016	56.17M
June 30, 2016	54.83M
June 30, 2016	54.83M
December 31, 2015	69.46M
June 30, 2015	58.38M
June 30, 2015	58.38M
December 31, 2014	65.35M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

3.827M

Minimum

Dec 2022

25.64M

Maximum

Dec 2019

8.926M

Average

6.684M

Median

Jun 2023

Shareholders Equity (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC	96.27M
Verona Pharma PLC	168.27M
NuCana PLC	4.806M
Autolus Therapeutics PLC	527.84M
TC BioPharm (Holdings) PLC	1.364M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	17.67M
Total Liabilities (Quarterly)	6.628M